Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia

被引:34
|
作者
Sakabe, K [1 ]
Fukuda, N [1 ]
Wakayama, K [1 ]
Nada, T [1 ]
Shinohara, H [1 ]
Tamura, Y [1 ]
机构
[1] Natl Zentsuji Hosp, Dept Cardiol & Clin Res, Kagawa 7658507, Japan
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 94卷 / 04期
关键词
D O I
10.1016/j.amjcard.2004.04.067
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this prospective study, we found beneficial short-term effects from atorvastatin therapy, including effects on low-density lipoprotein subfractions and remnant-like lipoprotein particle cholesterol, antioxidant effects, and alterations in endothelial function that may be important in early benefit from statin therapy; some effects would support much earlier benefit than previously reported. We also found long-term effects of atorvastatin, including decreased plasminogen activator inhibitor type-1 and additional significant alterations in low-density lipoprotein subfractions and endothelial function, supporting benefits from continuous long-term atorvastatin therapy beyond early reversal of hypercholesterolemia. (C) 2004 by Excerpta Medica, Inc.
引用
收藏
页码:497 / 500
页数:4
相关论文
共 50 条
  • [21] Lipid-Altering Therapies and the Progression of Atherosclerotic Disease
    Anthony S. Wierzbicki
    CardioVascular and Interventional Radiology, 2007, 30 : 155 - 160
  • [22] Extralipid effects of atorvastatin in patients with hypercholesterolemia
    Herman, Z
    Okopien, B
    Krysiak, R
    Stachura-Kulach, A
    Kulach, A
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 96 - 97
  • [23] Lipid-altering efficacy of ER niacin/laropiprant in dyslipidemic patients with metabolic syndrome
    Bays, Harold E.
    MacCubbin, Darbie
    Shah, Arvind
    Lin, Jianxin
    Sisk, Christine McCrary
    Paolini, John F.
    DIABETES, 2008, 57 : A27 - A27
  • [24] Pleiotropic Effects of Atorvastatin on Monocytes in Atherosclerotic Patients
    Wang, Zhi-hao
    Liu, Xiao-lin
    Zhong, Ming
    Zhang, Li-ping
    Shang, Yuan-yuan
    Hu, Xiao-yan
    Li, Li
    Zhang, Yun
    Deng, Jing-ti
    Zhang, Wei
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (03): : 311 - 319
  • [25] Pleiotropic effects of fluvastatin on diabetic patients with hypercholesterolemia
    Hayashi, H
    Kasahata, N
    Kawamitsu, H
    Amakawa, T
    Murakami, E
    Yoshino, G
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 166 - 166
  • [26] Comparative evaluation of the effects of ezetimibe and atorvastatin on serum lipid profile changes in experimental hypercholesterolemia in cat
    Tarakameh Samani S.
    Mosallanejad B.
    Razi Jalali M.
    Jamshidian J.
    Avizeh R.
    Comparative Clinical Pathology, 2018, 27 (1) : 117 - 122
  • [27] Lipid-altering efficacy and safety profile of co-administered extended release niacin/laropiprant and simvastatin versus atorvastatin in patients with mixed hyperlipidemia
    Chen, Fabian
    Maccubbin, Darbie
    Yan, Lizhen
    Sirah, Waheeda
    Chen, Erluo
    Sisk, Christine McCrary
    Davidson, Michael
    Blomqvist, Peder
    McKenney, James M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (01) : 225 - 231
  • [28] Lipid-Altering Efficacy and Safety Profile of Co-Administered Extended Release Niacin/Laropiprant and Simvastatin Versus Atorvastatin in Patients With Mixed Hyperlipidemia
    Chen, Fabian
    Maccubbin, Darbie
    Yan, Lizhen
    Chen, Erluo
    Sisk, Christine Mccrary
    Mckenney, James
    Davidson, Michael
    Blomqvist, Peder
    CIRCULATION, 2011, 124 (21)
  • [29] Association between baseline LDL-C, TG, and HDL-C levels and the lipid-altering and hsCRP efficacy of ezetimibe/simvastatin versus atorvastatin in patients with type 2 diabetes and hypercholesterolemia: The VYTAL study
    Goldberg, Ronald B.
    Guyton, John R.
    Mazzone, Theodore
    Weinstock, Ruth S.
    Polls, Adam
    Tomassini, Joanne E.
    Tershakovec, Andrew M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 345A - 345A
  • [30] Effects of atorvastatin in patients with homozygous familial hypercholesterolemia
    Postiglione, A
    Montefusco, S
    Pauciullo, P
    Mancini, M
    Piliego, T
    ATHEROSCLEROSIS, 1999, 147 (02) : 423 - 424